Paraneoplastic encephalitis: clinically based approach on diagnosis and management

Area of Science:

• Neurology
• Oncology
• Immunology

Background:

• Paraneoplastic neurological syndromes (PNSs) are immune-mediated nervous system diseases associated with cancer.
• PNSs present with diverse clinical features, influenced by specific neural antibodies and disease progression rates.
• Recent updates to diagnostic criteria aim to improve specificity and standardize research.

Purpose of the Study:

• To summarize the current understanding of paraneoplastic neurological syndromes.
• To highlight the importance of updated diagnostic criteria for PNS.
• To discuss current treatment limitations and future research directions.

Main Methods:

• Review of existing literature on paraneoplastic neurological syndromes.
• Analysis of clinical presentations, diagnostic criteria, and treatment outcomes.
• Discussion of the immunological basis and potential therapeutic strategies for PNS.

Main Results:

• PNSs are characterized by subacute onset and rapid progression, leading to severe neurological disability.
• Clinical manifestations and outcomes vary based on associated neural antibodies.
• Current treatments, including oncological therapy and immunomodulation, have limited efficacy in reversing disability.

Conclusions:

• Despite challenges in treatment, advances in understanding PNS pathogenesis offer hope for improved recognition and diagnosis.
• PNS research provides insights into effective anticancer immunity with implications beyond neurology.
• Further research is crucial for developing novel and more effective therapeutic strategies for PNS.